NCI-cbiit-21-0091 covid-19 semantics and CDE support
Ended Awarded Last action
- Contract number
- 75N91021F00012
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $435,615
Award facts
- Contract value 100% obligated
- $435,615.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21703, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $435,615 |
About this award
This is a $435,615.00 cost-plus-fixed-fee delivery order awarded by the National Institutes of Health (NIH) National Cancer Institute to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for COVID-19 semantics and common data element (CDE) support and has a period of performance through May 31, 2023. Leidos Biomedical Research is a Federally Funded Research and Development Center (FFRDC) contractor for the National Cancer Institute, providing a broad range of biomedical research and facilities support services. This delivery order is likely part of the broader FFRDC contract, which has a potential value of $6.6 billion over a five-year base period from 2019 to 2024. The contract was not set aside for any specific business type.
Quick answers
Who was awarded contract 75N91021F00012?
75N91021F00012 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 1, 2021.
How much is contract 75N91021F00012 worth?
The government has obligated $435,615 on 75N91021F00012.
Is contract 75N91021F00012 an order under another contract?
Yes. 75N91021F00012 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91021F00012 competed?
The extent of competition for 75N91021F00012 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award